Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 469 shares at $56.39 ($26K) on 2025-02-12, disclosed to the SEC on 2025-02-14.
Scheduled sale ($26k) by Chief Technical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.39 | 462 | $26K | 98.5% |
| 2 | $57.09 | 7 | $400 | 1.5% |
| Total | $56.40 avg | 469 | $26K | 100% |
| Filing → |
| RYTM | SELL | 2025-10-30 | $648K | — | Filing → |
| RYTM | SELL | 2025-10-20 | $3.2M | — | Filing → |
| RYTM | SELL | 2025-09-04 | $3.5M | — | Filing → |